Back
Supernus Pharmaceuticals Stock Predictions
Invest in This AI Tech Innovator Doubling Revenue
Invest Now!
Sell
31
SUPN
Supernus Pharmaceuticals
Last Price:
31.98
Seasonality Move:
-3.54%
7 Day Trial
ALL ACCESS PASS
$
7
Supercharge Your Portfolio with This High-Traction AI Startup
Learn MoreSupernus Pharmaceuticals Stock Forecast
- Over the next 52 weeks, Supernus Pharmaceuticals has on average historically risen by 16.4% based on the past 12 years of stock performance.
- Supernus Pharmaceuticals has risen higher in 8 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Supernus Pharmaceuticals Stock Undervalued?
The current Supernus Pharmaceuticals [SUPN] share price is $32.03. The Score for SUPN is 31, which is 38% below its historic median score of 50, and infers higher risk than normal. - SUPN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Supernus Pharmaceuticals Stock Go Up Next Year?
- Over the next 52 weeks, Supernus Pharmaceuticals has on average historically risen by 16.4% based on the past 12 years of stock performance.
Supernus Pharmaceuticals Stock Rating
Sell
31
Supernus Pharmaceuticals (SUPN)
is a Sell
Is Supernus Pharmaceuticals overpriced?
- Supernus Pharmaceuticals has risen higher in 8 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Supernus Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
supernus.com
52-Week Data
52-Week High:
35.44
52-Week Low:
21.99
Prediction Charts
Market Cap:
1.77B
Price in USD:
32.03
Volume:
353.91K
Beta:
1.10
Technical Analysis
SMA50:
32.23
SMA100:
29.90
SMA200:
29.92
52-Wk Change:
16.18%
Stock Predictions
-
Is Supernus Pharmaceuticals stock public?
Yes, Supernus Pharmaceuticals is a publicly traded company. -
What is the Supernus Pharmaceuticals stock quote today?
The Supernus Pharmaceuticals stock price is 32.03 USD today. -
How to buy Supernus Pharmaceuticals stock online?
You can buy Supernus Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Sep-12 | 31.24 | 30.88 | 31.57 | 30.73 |
| Sep-13 | 31.22 | 31.11 | 31.62 | 30.99 |
| Sep-16 | 31.34 | 31.48 | 31.87 | 30.78 |
| Sep-17 | 31.62 | 31.72 | 31.95 | 31.58 |
| Sep-18 | 31.64 | 31.84 | 32.59 | 31.59 |
| Sep-19 | 32.26 | 32.12 | 32.26 | 31.78 |
| Sep-20 | 31.94 | 31.83 | 32.21 | 31.73 |
| Sep-23 | 31.73 | 31.42 | 31.74 | 30.97 |
| Sep-24 | 31.50 | 30.55 | 31.50 | 30.41 |
| Sep-25 | 30.60 | 29.94 | 30.60 | 29.74 |
| Sep-26 | 30.29 | 30.76 | 31.00 | 29.96 |
| Sep-27 | 30.85 | 30.75 | 31.40 | 30.63 |
| Sep-30 | 30.82 | 31.17 | 31.48 | 30.82 |
| Oct-1 | 31.10 | 32.03 | 32.32 | 30.83 |
Supernus Pharmaceuticals Earnings
Supernus Pharmaceuticals Earnings Report: Per Share Supernus Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Supernus Pharmaceuticals Forecast Revenue Growth
Supernus Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Supernus Pharmaceuticals and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and a decrease next year of $0.18 per share.
* Supernus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.